精准医疗时代的乳腺癌前哨淋巴结活检

doi:10.6040/j.issn.1671-7554.0.2022.0612

摘要/Abstract

摘要： 乳腺癌前哨淋巴结活检可使早期乳腺癌患者免于腋窝淋巴结清扫及其带来的并发症,已成为早期乳腺癌患者的标准手术方式之一。但是精准医疗时代下,乳腺癌前哨淋巴结活检在临床实施过程中仍存在定位不够准确、淋巴结过度切除等问题。针对这些问题,本研究团队建立了精准前哨淋巴结活检的齐鲁流程、提出了前哨淋巴结区域精细解剖理念,并报道了前哨淋巴结的解剖变异以及与上肢引流淋巴结的位置关系。研究成果对于早期乳腺癌患者腋窝淋巴引流的理解和腋窝淋巴结的手术具有重要意义。

关键词: 乳腺癌, 前哨淋巴结, 淋巴引流, 朗格腋弓

Abstract: Sentinel lymph node biopsy of breast cancer, which can avoid axillary lymph node dissection and its complications, has become one of the standard surgical methods for patients with early breast cancer. However, in the era of precision medicine, the clinical implementation of sentinel lymph node biopsy has problems such as inaccurate localization and excessive lymph node resection. In response, our research team has established the Qilu Procedure for precise sentinel lymph node biopsy, proposed the concept of fine anatomy of the sentinel lymph node region, and reported the anatomical variation of sentinel lymph nodes and the positional relationship with the upper extremity draining lymph nodes. The results of this study have important implications for the understanding of axillary lymphatic drainage and operation of axillary lymph nodes in patients with early breast cancer.

Key words: Breast cancer, Sentinel lymph node, Lymphatic drainage, Langers axillary arch

中图分类号:

R737.9

杨其峰,张宁. 精准医疗时代的乳腺癌前哨淋巴结活检[J]. 山东大学学报 (医学版), 2022, 60(8): 1-5.

YANG Qifeng, ZHANG Ning. Sentinel lymph node biopsy of breast cancer in the era of precision medicine[J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 1-5.

参考文献

[1] Giammarile F, Vidal-Si S, Paez D, et al. Sentinel Lymph Node Methods in Breast Cancer [J]. Semin Nucl Med, 2022, S0001-2998(22)00006-X. doi: 10.1053/j.semnuclmed.2022.01.006.
[2] Noguchi M, Inokuchi M, Noguchi M, et al. Axillary surgery for breast cancer: past, present, and future [J]. Breast Cancer, 2021, 28(1): 9-15.
[3] Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011(Alliance)randomized clinical trial [J]. JAMA, 2017, 318(10): 918-926.
[4] Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial [J]. Lancet Oncol, 2007, 8(10): 881-888.
[5] 中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2021年版)[J]. 中国癌症杂志, 2021, 31(10): 87.
[6] Wise J. Breast cancer: NICE recommends innovative magnetic technology for locating sentinel lymph nodes [J]. BMJ, 2022, 377: o1226. doi: 10.1136/bmj.o1226.
[7] Vidya R, Khosla M, Laws S, et al. Axillary sentinel lymph node identification using superparamagnetic iron oxide versus radioisotope in early stage breast cancer: the UK SentiMag trial(SMART study)[J]. Surgeon, 2022, S1479-666X(22)00063-4. doi: 10.1016/j.surge.2022.04.006.
[8] Micha A, Parvaiz MA, ORiordan L, et al. Isotope-only localization for sentinel lymph node biopsy-medium-term oncological outcomes [J]. Clin Breast Cancer, 2022, 22(5):e636-e640.
[9] Zhu Y, Fan X, Yang D, et al. Contrast-enhanced ultrasound for precise sentinel lymph node biopsy in women with early breast cancer:a preliminary study [J]. Diagnostics(Basel), 2021, 11(11):2104. doi: 10.3390/diagnostics11112104.
[10] Shimazu K, Miyake T, Tanei T, et al. Real-time visualization of lymphatic flow to sentinel lymph nodes by contrast-enhanced ultrasonography with sonazoid in patients with breast cancer [J]. Ultrasound Med Biol, 2019, 45(10): 2634-2640.
[11] Li J, Li H, Guan L, et al. The value of preoperative sentinel lymph node contrast-enhanced ultrasound for breast cancer: a large, multicenter trial [J]. BMC Cancer, 2022, 22(1): 455. doi: 10.1186/s12885-022-09551-y.
[12] Zeng HC, Hu JL, Bai JW, et al. Detection of sentinel lymph nodes with near-infrared imaging in malignancies [J]. Mol Imaging Biol, 2019, 21(2): 219-227.
[13] Wang Z, Yang X, Wang J, et al. Real-time in situ navigation system with indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer [J]. Front Oncol, 2021, 11: 621914. doi: 10.3389/fonc.2021.621914. eCollection 2021.
[14] Li C, Liu P, Shao P, et al. Handheld projective imaging device for near-infrared fluorescence imaging and intraoperative guidance of sentinel lymph node resection [J]. J Biomed Opt, 2019, 24(8): 1-4.
[15] Wen S, Liang Y, Kong X, et al. Application of preoperative computed tomographic lymphography for precise sentinel lymph node biopsy in breast cancer patients [J]. BMC Surg, 2021, 21(1): 187. doi: 10.1186/s12893-021-01190-7.
[16] Li X, Chen S, Jiang L, et al. Precise intraoperative sentinel lymph node biopsies guided by lymphatic drainage in breast cancer [J]. Oncotarget, 2017, 8(38): 63064-63072.
[17] Xu L, Yang J, Du Z, et al. Redefining criteria to ensure adequate sentinel lymph node biopsy with dual tracer for breast cancer [J]. Front Oncol, 2020, 10: 588067. doi: 10.3389/fonc.2020.588067. eCollection 2020.
[18] Larson KE, Valente SA, Tu C, et al. Surgeon-associated variation in breast cancer staging with sentinel node biopsy [J]. Surgery, 2018, 164(4): 680-686.
[19] Olaya W, Wong J, Wong J, et al. When is a lymph node dissection a lymph node dissection? the number of lymph nodes resected in sentinel and axillary lymph node dissections [J]. Ann Surg Oncol, 2013, 20(2): 627-632.
[20] Dutta R, Kluftinger A, Macleod M, et al. Revisiting the “10% rule” in breast cancer sentinel lymph node biopsy: an approach to minimize the number of sentinel lymph nodes removed [J]. Am J Surg, 2012, 203(5): 623-627.
[21] Li X, Chen S, Duan Y, et al. Identification and preservation of stained non-sentinel lymph nodes in breast cancer [J]. Oncol Lett, 2020, 20(6): 373. doi: 10.3892/ol.2020.12236. Epub 2020 Oct 21.
[22] Li X, Kong X, Chen S, et al. Enlarged para-sentinel lymph node dissection is not necessary in breast cancer patients undergoing sentinel lymph node biopsy [J]. Breast J, 2019, 25(5): 1025-1028.
[23] Disipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis [J]. Lancet Oncol, 2013, 14(6): 500-515.
[24] Mclaughlin SA, Brunelle CL, Taghian A. Breast cancer-related lymphedema: risk factors, screening, management, and the impact of locoregional treatment [J]. J Clin Oncol, 2020, 38(20): 2341-2350.
[25] Ma X, Wen S, Liu B, et al. Relationship between upper extremity lymphatic drainage and sentinel lymph nodes in patients with breast cancer [J]. J Oncol, 2019, 2019: 8637895. doi: 10.1155/2019/8637895.?eCollection 2019.
[26] Shao X, Sun B, Shen Y. Axillary reverse mapping(ARM): where to go [J]. Breast Cancer, 2019, 26(1): 1-10.
[27] Daniels IR, della Rovere GQ. The axillary arch of Langer - the most common muscular variation in the axilla [J]. Breast Cancer Res Treat, 2000, 59(1): 77-80.
[28] Baskin AS, Wang K, Maker AV. Langers arch: an anatomic variant complicating axillary node dissection [J]. Surgery, 2022, S0039-6060(22)00080-0. doi: 10.1016/j.surg.2022.02.001.
[29] Sang Y, Kong X, Li X, et al. Langers axillary arch lymph node metastasis in breast cancer patients: A prospective clinical study [J]. Surg Oncol, 2019, 29: 48-52. doi: 10.1016/j.suronc.2019.03.003. Epub 2019 Mar 2.
[30] Borm KJ, Ernst L, Voppichler J, et al. Comparison of the distribution of lymph node metastases compared to healthy lymph nodes in breast cancer [J]. Radiat Oncol, 2022, 17(1): 27. doi: 10.1186/s13014-021-01964-6.

相关文章 15

[1]	林芸,谢燕秋. 乳腺癌患者生育力保护及保存[J]. 山东大学学报 (医学版), 2022, 60(9): 42-46.
[2]	贺士卿,李皖皖,董书晴,牟婧怡,刘宇莹,魏思雨,刘钊,张家新. 基于数据库构建乳腺癌焦亡相关基因的预后风险模型[J]. 山东大学学报 (医学版), 2022, 60(8): 34-43.
[3]	赵婷婷,齐亚娜,张颖,袁冰,韩明勇. 小鼠乳腺癌诱导转移前肺组织微环境的改变[J]. 山东大学学报 (医学版), 2022, 60(4): 24-29.
[4]	封海岗,刘国文,曹洪. 干扰MAD2L1基因表达对乳腺癌细胞凋亡的影响及机制[J]. 山东大学学报 (医学版), 2022, 60(10): 9-16.
[5]	初竹秀,赵文静,李小燕,孔晓丽,马婷婷,江立玉,杨其峰. 218例女性乳腺癌患者行新辅助化疗及伴随分子标志物改变的临床价值[J]. 山东大学学报 (医学版), 2021, 59(9): 130-139.
[6]	王喆,刘玉洁,毛倩,管佩霞,包绮晗,李承圣,乔晓伟,潘庆忠,王素珍. 基于逆概率加权法的早期三阴性乳腺癌不同治疗方案的疗效评价[J]. 山东大学学报 (医学版), 2021, 59(8): 113-118.
[7]	李皖皖,周文凯,董书晴,贺士卿,刘钊,张家新,刘斌. 利用数据库信息构建乳腺癌免疫关联lncRNAs风险评估模型[J]. 山东大学学报 (医学版), 2021, 59(7): 74-84.
[8]	孔雪,李娟,段伟丽,史爽,李培龙,杜鲁涛,毛海婷,王传新. 长链非编码RNA AC012073.1对乳腺癌细胞迁移侵袭的影响及临床价值[J]. 山东大学学报 (医学版), 2021, 59(4): 70-78.
[9]	郭田,付依林,高聆,宋勇峰,付国斌,耿冲,王潍博. 142例女性乳腺癌患者临床特征与甲状腺激素水平的关联分析[J]. 山东大学学报 (医学版), 2020, 58(6): 53-59.
[10]	杨雪梅,李娟,王一凡,李培龙,王允山,杜鲁涛,王传新. 3-lncRNAs预后模型在HER2阳性乳腺癌预后评价中的意义[J]. 山东大学学报 (医学版), 2020, 58(5): 69-76.
[11]	高奎,万广宁,宋晓鹏,信波. 吡咯替尼治疗曲妥珠耐药HER2阳性乳腺癌1例[J]. 山东大学学报 (医学版), 2020, 58(12): 117-120.
[12]	孙志刚,时鹏,田兴松. 乳腺癌术后促纤维增生性肌纤维母细胞瘤1例[J]. 山东大学学报 (医学版), 2020, 58(1): 121-124.
[13]	栾娜,刘丽媛,王斐,周飞,相玉娟,黄淑亚,郑超,于理想,余之刚. 乳腺癌患者睡眠质量及相关因素分析[J]. 山东大学学报 (医学版), 2019, 57(4): 59-64.
[14]	盛璇,李梦娇,兰梦,丁红宇. 乳腺导管内乳头状瘤外伤后超声表现1例[J]. 山东大学学报 (医学版), 2018, 56(12): 123-124.
[15]	李弋,彭静,张蕾,陆劲松. 异甘草酸镁对乳腺癌细胞系生物学行为的影响及作用机制[J]. 山东大学学报 (医学版), 2018, 56(1): 38-44.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed